Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by G1945Von May 25, 2023 8:38am
70 Views
Post# 35463307

RE:Unbeliveable

RE:Unbeliveable
GrahamB wrote: So we have a few posts that are misleading at best.

An old dear friend letter 

An unsupported claim that Brazil is in play-despite the focus on Alviras call clearly indicated this isnt the case (see below*)

the price goes up on low volume-what 30k

Did a newbie believe and buy?

Doesnt matter-sustained price action requires new-real sales

Unbeliveable

*"The key market segment that we are going after is the congenital market, and this includes adult and paediatric. This is where Ventripoint started from, and this is where we need to get the strongest foothold, establish our reputation in this field as being the leader so that we can then branch out into the other key market segments. Our target geographies, as I mentioned, United States, UK and Europe, that is where our focus is these days in terms of sales"



"Did a newbie believe and buy?"

Seriously!

G1945V

<< Previous
Bullboard Posts
Next >>